Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salsalate for Endothelial Dysfunction in HIV
NCT01046682Phase 2Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Jan 2009
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Amigesic in endothelial dysfunction, inflammation, insulin resistance (IR), sponsored by University Hospitals Cleveland Medical Center. Started Jan 2009; status: completed.
02
Drugs
Amigesic
03
Conditions
endothelial dysfunctioninflammationinsulin resistance (IR)
Beyond the preview
Go deeper on NCT01046682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01046682.